MedPath

JOHNSON & JOHNSON (HONG KONG) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

104

PPB:104

Drug Approvals

VERASEAL SOLUTIONS FOR SEALANT 10ML

Approval Date
May 23, 2025
PPB

VERASEAL SOLUTIONS FOR SEALANT 4ML

Approval Date
May 23, 2025
PPB

VERASEAL SOLUTIONS FOR SEALANT 2ML

Approval Date
May 23, 2025
PPB

TALVEY SOLUTION FOR INJECTION 40MG/1ML

Approval Date
Dec 16, 2024
PPB

TALVEY SOLUTION FOR INJECTION 3MG/1.5ML

Approval Date
Dec 16, 2024
PPB

AKEEGA TABLETS 100MG/500MG

Approval Date
Jul 9, 2024
PPB

AKEEGA TABLETS 50MG/500MG

Approval Date
Jul 9, 2024
PPB

TECVAYLI SOLUTION FOR INJECTION 30MG/3ML

Approval Date
Feb 23, 2024
PPB

TECVAYLI SOLUTION FOR INJECTION 153MG/1.7ML

Approval Date
Feb 23, 2024
PPB

INVEGA HAFYERA PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 700MG/3.5ML

Approval Date
Nov 7, 2023
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.